Manuka Honey Should NOT Be Used for Pyoderma Gangrenosum
Do not use Manuka honey or any honey-based products as a topical treatment for pyoderma gangrenosum. There is no evidence supporting its use for this specific condition, and established guidelines recommend proven immunosuppressive therapies instead.
Why Honey Is Not Recommended
The evidence landscape is clear on this point:
No specific evidence exists for honey in treating pyoderma gangrenosum. While honey has been studied in other wound types (diabetic foot ulcers, Fournier's gangrene), pyoderma gangrenosum is fundamentally different—it is an inflammatory neutrophilic dermatosis, not a typical wound or infection 1.
The 2024 IWGDF guidelines explicitly state: "Do not use honey (or bee-related products) for the purpose of wound healing in diabetes-related foot ulcers" with a strong recommendation based on low-quality evidence 2. While this addresses diabetic ulcers specifically, it reflects the broader lack of evidence for honey in complex inflammatory wounds.
Pyoderma gangrenosum exhibits pathergy—trauma or manipulation worsens the condition 1. Applying topical agents without appropriate immunosuppression could theoretically aggravate lesions.
What Actually Works for Pyoderma Gangrenosum
The evidence-based treatment algorithm is straightforward:
First-Line Treatment
Systemic corticosteroids (topical and/or systemic) are the established first-line therapy 3.
Second-Line for Inadequate Response
If rapid response to corticosteroids is not achieved, escalate to:
The landmark trial showed infliximab 5 mg/kg achieved 46% improvement at week 2 versus 6% with placebo (p=0.025), with response rates exceeding 90% in lesions present <12 weeks 4, 1.
Alternative Options
- Topical or oral calcineurin inhibitors (tacrolimus, pimecrolimus) with dermatology consultation 4, 1, 3
- Ciclosporin for refractory cases 1
Special Consideration
For peristomal pyoderma gangrenosum, stoma closure may lead to lesion resolution 4, 1.
Critical Pitfalls to Avoid
Do not treat pyoderma gangrenosum like an infection—the purulent material is sterile unless secondary infection occurs 1. Antimicrobial approaches miss the underlying pathophysiology.
Avoid excessive wound manipulation—pathergy can worsen lesions 3.
Do not delay immunosuppression—early aggressive treatment (especially in lesions <12 weeks duration) achieves superior outcomes 4, 1.
Coordinate wound care with specialists—daily wound care should involve wound-care specialists alongside immunosuppressive therapy 1.
Why the Confusion About Honey?
Medical-grade Manuka honey does have antimicrobial properties and has been studied in other wound contexts 5, 6, 7, 8. However, pyoderma gangrenosum is not primarily a wound healing problem—it is an immune-mediated inflammatory disease requiring immunosuppression, not antimicrobial or wound-healing agents 1, 9.
The pathogenesis involves dysregulated innate and adaptive immunity with elevated TNF-α, IL-1, IL-8, IL-17, and IL-23 9. This requires targeted immunosuppression, not topical wound treatments.